PRESS RELEASE published on 11/27/2025 at 15:57, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. submits Form 8.3 disclosing 5.73% ownership of Avadel Pharmaceuticals plc. Details on securities, derivatives, and dealings provided Form 8.3 Securities Dealings Vanguard Group Inc. Ownership Disclosure Avadel Pharmaceuticals Plc
PRESS RELEASE published on 11/27/2025 at 15:56, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.33% position in Greencore Group plc. Details of open positions and recent dealings provided Relevant Securities Position Disclosure Vanguard Group Dealings Greencore Group Plc
PRESS RELEASE published on 11/27/2025 at 15:54, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses a 1.23% stake in Bluefield Solar Income Fund Limited as of 26th November 2025 Financial Report The Vanguard Group Stock Market Stake Disclosure Bluefield Solar Income Fund Limited
PRESS RELEASE published on 11/27/2025 at 15:53, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% stake in Spire Healthcare Group plc. Purchase and sale of 1p ordinary shares reported Shares Disclosure Vanguard Group Spire Healthcare Stakes
PRESS RELEASE published on 11/27/2025 at 15:52, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses 5.49% stake in Dowlais Group plc. American Axle & Manufacturing Holdings, Inc. also involved Vanguard Group Financial Disclosure Stake Disclosure Dowlais Group Plc American Axle
PRESS RELEASE published on 11/27/2025 at 15:50, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Empiric Student Property plc The Vanguard Group, Inc. discloses a 1.86% interest in Empiric Student Property plc. Details in Form 8.3 submission on Rule 8 of Takeover Code Form 8.3 Disclosure The Vanguard Group Takeover Code Empiric Student Property Plc
PRESS RELEASE published on 11/27/2025 at 15:49, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc The Vanguard Group, Inc. discloses a 1.11% interest in Petershill Partners plc's USD 0.01 ordinary securities. Transaction details revealed Securities Transactions Disclosure The Vanguard Group Petershill Partners Plc
PRESS RELEASE published on 11/27/2025 at 15:47, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc The Vanguard Group, Inc. disclosed a 1.66% stake in Bakkavor Group plc through 9,644,655 relevant securities. Additional disclosure for Greencore Group plc. Detailed dealings in 2p ordinary securities Securities Dealing Disclosure The Vanguard Group Stake Disclosure Bakkavor Group Plc
PRESS RELEASE published on 11/27/2025 at 15:46, 2 months ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 5.36% stake in Just Group plc as of 26 Nov 2025. Details of holdings and transactions provided Securities Form 8.3 Disclosure The Vanguard Group Just Group Plc
PRESS RELEASE published on 11/27/2025 at 15:44, 2 months ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses 1.22% stake in International Personal Finance plc. Public position disclosure under Rule 8.3 Position Disclosure Rule 8.3 Vanguard Group Stake International Personal Finance Plc
Published on 01/28/2026 at 05:35, 3 hours 50 minutes ago Banyan Gold Intersects High-Grades and Visible Gold at AurMac, Yukon, Canada
Published on 01/28/2026 at 01:00, 8 hours 25 minutes ago Boron One Announces Increase to Private Placement
Published on 01/27/2026 at 22:15, 11 hours 10 minutes ago Biomind Labs Announces CAD $2.52 Million Private Placement Financing
Published on 01/27/2026 at 20:20, 13 hours 5 minutes ago FutureGen Industries is Unaware of Any Material Change
Published on 01/28/2026 at 09:00, 24 minutes ago Original-Research: The Platform Group SE & Co. KGaA (von NuWays AG): BUY
Published on 01/28/2026 at 07:30, 1 hour 55 minutes ago Biophytis enters strategic agreement in Asia and secures $20 million for launch of Phase 3 trial in sarcopenia
Published on 01/28/2026 at 07:30, 1 hour 55 minutes ago Biophytis conclut un accord stratégique en Asie et sécurise 20 M$ pour le lancement de sa Phase 3 dans la sarcopénie
Published on 01/27/2026 at 19:00, 14 hours 25 minutes ago MISE A DISPOSITION RAPPORT FINANCIER SEMESTRIEL 2025/2026
Published on 01/27/2026 at 19:00, 14 hours 25 minutes ago RAPPORT FINANCIER SEMESTRIEL 25/26 TFF GROUP
Published on 01/27/2026 at 19:00, 14 hours 25 minutes ago RAPPORT FINANCIER SEMESTRIEL 25/26 TFF GROUP
